Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
about
Cutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis.Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatmentCo-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisTreatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.Diabetes tolerogenic vaccines targeting antigen-specific inflammationTopical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin.Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.Dexamethasone promotes tolerance in vivo by enriching CD11clo CD40lo tolerogenic macrophages.Attenuation of antigenic immunogenicity by kynurenine, a novel suppressive adjuvant.Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated Peptide and dexamethasone in acetalated dextran microparticlesCa2+ signaling in the regulation of dendritic cell functions.Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics.Vitamin D Deficiency and Rheumatoid Arthritis.A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease.The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice.FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis.Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis.Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism.Targeted IL-4 therapy synergizes with dexamethasone to induce a state of tolerance by promoting Treg cells and macrophages in mice with arthritis
P2860
Q34130293-73B1D18B-293E-408F-8423-41784CE1B414Q34875345-2289B900-812B-4854-B430-92DB0BF26188Q35318380-CB9E0EA6-C696-4E2D-94C9-0088100A843EQ35571156-373C3955-8D5F-4F69-B037-FF79F26E99FFQ35597747-DA05A491-9931-40E4-B95F-3A46A77F6ECAQ35887037-F0EEEC41-3EAF-4591-A8E0-1162463311D4Q36176416-1941169C-7F7B-4C0A-B897-F31416F24555Q36821113-859A1E26-3BAB-4026-8C8D-C8DDDB11B58BQ36968804-B65BF151-BB32-4F7F-A79B-A726804CB59DQ36977755-DDACA022-A275-4C6B-8B3C-5F232E1ED6D8Q37714122-4DA15138-BFFB-49E8-A962-B9F88CE71F58Q37859560-25FA9DD3-6A0B-41E7-A3A7-77B1E83E4A1BQ38645738-B2A89C9A-B334-414D-8C0A-A522221EEF49Q38916397-FC618AAD-477D-4C12-8EEA-544C4FE98B11Q40823850-3FAD7CE4-4903-44F2-99BD-FDF4BC048ED0Q41767127-A734B409-032C-413A-8CBC-F02B1AAA3CECQ43290322-862CBF15-8C80-4D65-AA46-850DE1AAE17DQ47617033-4F252F11-4D02-4F76-AA41-3983BB39DD37Q52678013-316A8540-2705-4059-BA83-4339B5E0A21BQ57911908-98EF1BE8-64CC-49D1-AA6E-873FA21C385B
P2860
Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
@ast
Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
@en
type
label
Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
@ast
Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
@en
prefLabel
Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
@ast
Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
@en
P2093
P2860
P1476
Cutting edge: Immunosuppressant as adjuvant for tolerogenic immunization
@en
P2093
Aoshuang Chen
Guoxing Zheng
Youmin Kang
P2860
P304
P356
10.4049/JIMMUNOL.180.8.5172
P407
P577
2008-04-01T00:00:00Z